Since its introduction for the treatment of strabismus, botulinum toxin (BoNT) has been increasingly used in the treatment of several disorders with excessive or inappropriate muscle contractions. The therapeutic effects of BoNT occur through the temporary chemodenervation caused by the injection into the local target muscle or skin. Modulation of muscle relaxation may be achieved by varying the dose of BoNT solution injected; most adverse effects are transient. Indeed, botulinum neurotoxin has been used to selectively weaken the internal anal sphincter as a treatment for chronic anal fissure in several randomized, controlled trials and open-label studies. The use of botulinum neurotoxin seems to be an effective and safe approach for the treatment of chronic anal fissure, particularly in patients at high risk for incontinence.

Brisinda, G., Cadeddu, F., Mazzeo, P., Maria, G. (2007). Botulinum toxin A for the treatment of chronic anal fissure. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 1(2), 219-228 [10.1586/17474124.1.2.219].

Botulinum toxin A for the treatment of chronic anal fissure

CADEDDU, FEDERICA;
2007-12-01

Abstract

Since its introduction for the treatment of strabismus, botulinum toxin (BoNT) has been increasingly used in the treatment of several disorders with excessive or inappropriate muscle contractions. The therapeutic effects of BoNT occur through the temporary chemodenervation caused by the injection into the local target muscle or skin. Modulation of muscle relaxation may be achieved by varying the dose of BoNT solution injected; most adverse effects are transient. Indeed, botulinum neurotoxin has been used to selectively weaken the internal anal sphincter as a treatment for chronic anal fissure in several randomized, controlled trials and open-label studies. The use of botulinum neurotoxin seems to be an effective and safe approach for the treatment of chronic anal fissure, particularly in patients at high risk for incontinence.
dic-2007
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/18 - CHIRURGIA GENERALE
English
Con Impact Factor ISI
Fissure in Ano; Humans; Neuromuscular Agents; Chronic Disease; Botulinum Toxins, Type A
Brisinda, G., Cadeddu, F., Mazzeo, P., Maria, G. (2007). Botulinum toxin A for the treatment of chronic anal fissure. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 1(2), 219-228 [10.1586/17474124.1.2.219].
Brisinda, G; Cadeddu, F; Mazzeo, P; Maria, G
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/35027
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact